> Detailanzeige

Arbon, Dominik; Ženíšková, Kateřina; Šubrtová, Karolína; Mach, Jan; Štursa, Jan; Machado, Marta; Zahedifard, Farnaz; Leštinová, Tereza; Hierro-Yap, Carolina; Neuzil, Jiri; Volf, Petr; Ganter, Markus; Zoltner, Martin; Zíková, Alena; Werner, Lukáš; Sutak, Robert

Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens
  • Beteiligte: Arbon, Dominik; Ženíšková, Kateřina; Šubrtová, Karolína; Mach, Jan; Štursa, Jan; Machado, Marta; Zahedifard, Farnaz; Leštinová, Tereza; Hierro-Yap, Carolina; Neuzil, Jiri; Volf, Petr; Ganter, Markus; Zoltner, Martin; Zíková, Alena; Werner, Lukáš; Sutak, Robert
  • Erschienen: American Society for Microbiology, 2022
  • Erschienen in: Antimicrobial Agents and Chemotherapy, 66 (2022) 8
  • Sprache: Englisch
  • DOI: 10.1128/aac.00727-22
  • ISSN: 0066-4804; 1098-6596
  • Schlagwörter: Infectious Diseases ; Pharmacology (medical) ; Pharmacology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>Many of the currently available anti-parasitic and anti-fungal frontline drugs have severe limitations, including adverse side effects, complex administration, and increasing occurrence of resistance. The discovery and development of new therapeutic agents is a costly and lengthy process.</jats:p>
  • Zugangsstatus: Freier Zugang